Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-295,935
Closed -$2.16M 112
2025
Q4
$2.16M Sell
295,935
-8,255
-3% -$80K 0.55% 53
2025
Q3
$3.03M Sell
304,190
-33,741
-10% -$373K 0.79% 50
2025
Q2
$3.06M Buy
337,931
+1,320
+0.4% +$8.61K 0.88% 47
2025
Q1
$2.16M Buy
336,611
+10,657
+3% +$94.8K 0.67% 50
2024
Q4
$3.1M Sell
325,954
-17,172
-5% -$151K 0.97% 43
2024
Q3
$2.8M Buy
343,126
+1,286
+0.4% +$13.4K 0.82% 50
2024
Q2
$4.62M Sell
341,840
-4,943
-1% -$41.3K 1.4% 35
2024
Q1
$2.43M Buy
346,783
+1,957
+0.6% +$17K 0.72% 52
2023
Q4
$3.78M Buy
344,826
+3,786
+1% +$37.2K 1.15% 46
2023
Q3
$3.75M Buy
+341,040
New +$4.87M 1.3% 40

Other funds holding ENVX

tru Independence's ENVX Position: Q1 2026 in Review

tru Independence sold out of Enovix (ENVX) in Q1 2026, closing a stake of 295,935 shares — an estimated $2.16M sold.

tru Independence first reported a position in ENVX in Q3 2023 and held it in 10 quarters. The position peaked at $4.62M in Q2 2024. 306 funds tracked by Wall St. Rank hold ENVX as of Q1 2026.

  • tru Independence reported no remaining Enovix position as of Q1 2026 after selling out during the quarter.
  • tru Independence sold 295,935 Enovix shares in Q1 2026, an estimated $2.16M.
  • tru Independence first reported a position in Enovix in Q3 2023 and held it in 10 quarters.
  • tru Independence's Enovix position peaked at $4.62M in Q2 2024.
  • 306 funds tracked by Wall St. Rank held Enovix as of Q1 2026.

Based on tru Independence's 13F filing for Q1 2026, filed 22 Apr 2026.